Find uplifting stories about heroes, innovations, and solutions
6288 results for "tick-borne disease"
Arizona State University researchers just cracked a mystery that could lead to new treatments for tularemia, a deadly tick-borne disease so potent that just 10 bacterial cells can cause infection. For the first time, scientists isolated and studied the proteins that help this dangerous pathogen survive inside human cells.
A groundbreaking study of 3,000 patients shows a blood transfusion method slashes death rates from severe babesiosis by nearly three-quarters. The findings offer hope for those battling the tick-borne illness spreading with climate change.
A University of Kentucky scientist is turning Lyme disease bacteria against itself in a promising new treatment approach. The breakthrough comes as tick-borne illnesses have jumped 128% nationwide since 2020.
A new Lyme disease vaccine from Pfizer has shown 70% effectiveness in clinical trials, offering hope for protection against the tick-borne illness that affects hundreds of thousands annually. This marks the first promising Lyme vaccine in over two decades.
A new vaccine could soon protect people from Lyme disease for the first time in over 20 years. Pfizer and Valneva's candidate showed over 70% effectiveness in preventing the tick-borne illness that affects hundreds of thousands annually.
A pharmaceutical company has achieved a 100% cure rate for a dangerous tick-borne disease in patients whose immune systems couldn't fight it off. The breakthrough could reshape treatment guidelines for babesiosis, a debilitating illness that often strikes alongside Lyme disease.
Google seeks approval to release 32 million specially treated mosquitoes in Florida and California to combat West Nile virus and other deadly diseases. The innovative approach uses bacteria and AI-powered robotics to reduce disease-carrying mosquito populations without adding more biters.
The federal government just announced one of the most ambitious campaigns ever to fight Lyme disease, which affects nearly half a million Americans every year. New tick control programs, AI-powered diagnostics, and $2.5 million in innovation prizes aim to turn the tide on this growing health threat.
A groundbreaking Lyme disease vaccine has proven 73% effective in major trials, bringing hope to millions at risk from tick-borne illness. After decades without protection, regulatory approval could arrive soon for people ages five and up.
Researchers discovered how to disguise healthy mitochondria so they can slip into diseased cells undetected, extending the lives of mice with a fatal genetic disorder. The breakthrough could one day help children born with rare mitochondrial diseases.
An island where 15% of residents have contracted Lyme disease is trying something unprecedented: specially bred mice that can't spread the bacteria to ticks. MIT researchers believe these tiny helpers could break the disease cycle that's plagued Nantucket for decades.
A simple trail trick could make walks in the woods safer for everyone. University of Ottawa researchers discovered that spreading woodchips on forest paths cuts tick populations dramatically.
Scientists at Monash University discovered a tick protein that blocks immune signals linked to multiple sclerosis, rheumatoid arthritis, and cancer. This natural protein could lead to more effective treatments for diseases that currently have limited options.
A small clinical trial achieved a perfect cure rate for a stubborn tick-borne illness that can last for years in people with weakened immune systems. The breakthrough offers hope for thousands of Americans suffering from chronic babesiosis.
A groundbreaking treatment for Huntington's disease just cleared a major hurdle, bringing hope to 240,000 Americans affected by this devastating condition. The experimental therapy could become the first disease-modifying treatment for a disorder that has had none.
A groundbreaking treatment for myotonic dystrophy type 1 reduced toxic proteins by 40% and improved muscle function in patients who've never had disease-modifying options. The New England Journal of Medicine just published results that could lead to the first approved therapy for this progressive, often fatal disease.
A new treatment for a rare kidney disease just passed a major test, bringing hope to 330,000 patients in the U.S. and Europe. Vertex's drug successfully reduced a key disease marker by half in late-stage trials.
Scientists at Monash University discovered a tick protein that blocks two types of immune signals at once, a breakthrough that could lead to more effective treatments for rheumatoid arthritis, multiple sclerosis, and other inflammatory diseases. This natural protein works differently than anything found before.
Pearl Jam's Eddie Vedder and Canadian director Matt Finlin created a documentary following the race to cure epidermolysis bullosa, a devastating skin disease affecting children worldwide. The Netflix film captures breakthrough research that could unlock treatments for thousands of rare diseases.
For the first time, a gene therapy has shown dramatic results in slowing Huntington's disease, offering hope to 8,000 UK families who've had no treatment options until now. Patients receiving the higher dose experienced 75% less disease progression over three years.
Showing 20 of 6288